Davide Campari-Milano Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Davide Campari-Milano de 15.7% y 6% por año respectivamente. Se prevé que el BPA crezca en un 14% al año. Se espera que la rentabilidad financiera sea de 11.8% en 3 años.
Información clave
15.7%
Tasa de crecimiento de los beneficios
14.0%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Beverage | 11.3% |
Tasa de crecimiento de los ingresos | 6.0% |
Rentabilidad financiera futura | 11.8% |
Cobertura de analistas | Good |
Última actualización | 13 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
With A 26% Price Drop For Davide Campari-Milano N.V. (BIT:CPR) You'll Still Get What You Pay For
Nov 17Calculating The Fair Value Of Davide Campari-Milano N.V. (BIT:CPR)
Oct 20Davide Campari-Milano (BIT:CPR) Has A Somewhat Strained Balance Sheet
Oct 04Getting In Cheap On Davide Campari-Milano N.V. (BIT:CPR) Is Unlikely
Jul 31It's Probably Less Likely That Davide Campari-Milano N.V.'s (BIT:CPR) CEO Will See A Huge Pay Rise This Year
Apr 05Davide Campari-Milano N.V.'s (BIT:CPR) Popularity With Investors Is Clear
Mar 30Investors Appear Satisfied With Davide Campari-Milano N.V.'s (BIT:CPR) Prospects
Dec 27Returns At Davide Campari-Milano (BIT:CPR) Appear To Be Weighed Down
Dec 15Does Davide Campari-Milano (BIT:CPR) Have A Healthy Balance Sheet?
Nov 19Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?
Oct 22Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching
Oct 10Is Davide Campari-Milano (BIT:CPR) Using Too Much Debt?
Aug 12Returns On Capital At Davide Campari-Milano (BIT:CPR) Have Stalled
Jul 29Here's Why We Think Davide Campari-Milano (BIT:CPR) Is Well Worth Watching
Jun 29These 4 Measures Indicate That Davide Campari-Milano (BIT:CPR) Is Using Debt Reasonably Well
May 05Here's What To Make Of Davide Campari-Milano's (BIT:CPR) Decelerating Rates Of Return
Apr 22Here's Why Davide Campari-Milano N.V.'s (BIT:CPR) CEO Might See A Pay Rise Soon
Apr 07If EPS Growth Is Important To You, Davide Campari-Milano (BIT:CPR) Presents An Opportunity
Mar 23Davide Campari-Milano (BIT:CPR) Shareholders Will Want The ROCE Trajectory To Continue
Jan 13Should You Be Adding Davide Campari-Milano (BIT:CPR) To Your Watchlist Today?
Nov 18Returns At Davide Campari-Milano (BIT:CPR) Are On The Way Up
Oct 15Is Davide Campari-Milano (BIT:CPR) A Risky Investment?
Oct 02Does Davide Campari-Milano (BIT:CPR) Deserve A Spot On Your Watchlist?
Aug 16Are Davide Campari-Milano N.V. (BIT:CPR) Investors Paying Above The Intrinsic Value?
Jul 31We Think Davide Campari-Milano (BIT:CPR) Can Manage Its Debt With Ease
Jun 22There's Been No Shortage Of Growth Recently For Davide Campari-Milano's (BIT:CPR) Returns On Capital
Jun 07Davide Campari-Milano (BIT:CPR) Has A Rock Solid Balance Sheet
Mar 17Davide Campari-Milano (BIT:CPR) Has Some Way To Go To Become A Multi-Bagger
Feb 28Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 3,418 | 458 | 363 | N/A | 18 |
12/31/2025 | 3,219 | 394 | 206 | N/A | 19 |
12/31/2024 | 3,032 | 343 | 20 | N/A | 20 |
9/30/2024 | 2,994 | 308 | N/A | N/A | N/A |
6/30/2024 | 2,984 | 333 | -34 | 415 | N/A |
3/31/2024 | 2,914 | 342 | N/A | N/A | N/A |
12/31/2023 | 2,919 | 331 | -159 | 157 | N/A |
9/30/2023 | 2,922 | 512 | N/A | N/A | N/A |
6/30/2023 | 2,899 | 351 | -45 | 214 | N/A |
3/31/2023 | 2,737 | 367 | N/A | N/A | N/A |
12/31/2022 | 2,698 | 333 | 25 | 380 | N/A |
9/30/2022 | 2,563 | 329 | 90 | 396 | N/A |
6/30/2022 | 2,429 | 324 | 155 | 412 | N/A |
3/31/2022 | 2,301 | 305 | 246 | 448 | N/A |
12/31/2021 | 2,173 | 285 | 338 | 484 | N/A |
9/30/2021 | 2,088 | 280 | 306 | 447 | N/A |
6/30/2021 | 2,004 | 275 | 274 | 410 | N/A |
3/31/2021 | 1,888 | 231 | 233 | 344 | N/A |
12/31/2020 | 1,772 | 188 | 193 | 278 | N/A |
9/30/2020 | 1,768 | 223 | 195 | 284 | N/A |
6/30/2020 | 1,763 | 259 | 197 | 291 | N/A |
3/31/2020 | 1,803 | 284 | 234 | 327 | N/A |
12/31/2019 | 1,843 | 308 | 271 | 363 | N/A |
9/30/2019 | 1,812 | 290 | 245 | 334 | N/A |
6/30/2019 | 1,782 | 272 | 218 | 304 | N/A |
3/31/2019 | 1,747 | 284 | 231 | 316 | N/A |
12/31/2018 | 1,712 | 296 | 245 | 328 | N/A |
9/30/2018 | 1,714 | 346 | 243 | 323 | N/A |
6/30/2018 | 1,715 | 395 | N/A | 319 | N/A |
3/31/2018 | 1,734 | 376 | N/A | 315 | N/A |
12/31/2017 | 1,753 | 356 | N/A | 311 | N/A |
9/30/2017 | 1,776 | 282 | N/A | 300 | N/A |
6/30/2017 | 1,799 | 208 | N/A | 289 | N/A |
3/31/2017 | 1,763 | 187 | N/A | 342 | N/A |
12/31/2016 | 1,727 | 166 | N/A | 395 | N/A |
9/30/2016 | 1,685 | 166 | N/A | 415 | N/A |
6/30/2016 | 1,643 | 165 | N/A | 435 | N/A |
3/31/2016 | 1,650 | 170 | N/A | 370 | N/A |
12/31/2015 | 1,657 | 175 | N/A | 305 | N/A |
9/30/2015 | 1,644 | 162 | N/A | 305 | N/A |
6/30/2015 | 1,632 | 150 | N/A | 304 | N/A |
3/31/2015 | 1,596 | 139 | N/A | 294 | N/A |
12/31/2014 | 1,560 | 129 | N/A | 283 | N/A |
9/30/2014 | 1,536 | 139 | N/A | 254 | N/A |
6/30/2014 | 1,512 | 150 | N/A | 226 | N/A |
3/31/2014 | 1,518 | 150 | N/A | 223 | N/A |
12/31/2013 | 1,524 | 150 | N/A | 221 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (15.7% al año) de CPR es superior a la tasa de ahorro (2.5%).
Beneficios vs. Mercado: Se prevé que los beneficios (15.7% al año) de CPR crezcan más rápidamente que el mercado Italian (7.3% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de CPR crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (6% al año) de CPR crezcan más rápidamente que los del mercado Italian (4% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 6% al año) de CPR crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CPR sea baja dentro de 3 años (11.8%).